Your browser doesn't support javascript.
Breast Cancer and SARS-Cov2: Lessons from a Pandemic.
Gosset, Marie; Gal, Jocelyn; Schiappa, Renaud; Helwig, Christopher; Bonomo, Iris; Delpech, Yann; Barranger, Emmanuel.
  • Gosset M; Département de Chirurgie Sénologique et Onco-Gynécologique, Centre Antoine-Lacassagne, Nice, France; marie.gosset@nice.unicancer.fr.
  • Gal J; Département d'Epidémiologie, de Biostatistiques et des Données de Santé (DEBDS), Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
  • Schiappa R; Département d'Epidémiologie, de Biostatistiques et des Données de Santé (DEBDS), Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
  • Helwig C; Département de Chirurgie Sénologique et Onco-Gynécologique, Centre Antoine-Lacassagne, Nice, France.
  • Bonomo I; Département de Chirurgie Sénologique et Onco-Gynécologique, Centre Antoine-Lacassagne, Nice, France.
  • Delpech Y; Département de Chirurgie Sénologique et Onco-Gynécologique, Centre Antoine-Lacassagne, Nice, France.
  • Barranger E; Département de Chirurgie Sénologique et Onco-Gynécologique, Centre Antoine-Lacassagne, Nice, France.
Anticancer Res ; 43(5): 2235-2241, 2023 May.
Article in English | MEDLINE | ID: covidwho-2295738
ABSTRACT
BACKGROUND/

AIM:

The COVID-19 pandemic introduced drastic containment measures, which had a direct impact on breast cancer management. During the first wave, a delay in care and a decrease in new consultation numbers was observed. It would be interesting to study the resulting long-term consequences on breast cancer presentation and time to first treatment. PATIENTS AND

METHODS:

This retrospective cohort study was conducted at the surgery Department of the Anti-Cancer Center of Nice, France. Two periods of 6 months were compared a pandemic period from June to December 2020 (after the end of the first wave), and a control period one year earlier. The primary endpoint was to measure the time to care access. The patients and cancer characteristics and the management type were also compared.

RESULTS:

A total of 268 patients underwent diagnosis for breast cancer in each period. The time from biopsy to consultation was shortened after the containment was lifted (16 days vs. 18 days, p=0.024). The time between first consultation and treatment was unchanged between the two periods. The tumor size was larger in the pandemic period (21 mm vs. 18 mm, p=0.028). The clinical presentation was different 59.8% of patients consulted for a palpable mass in the pandemic period, vs. 49.6% in the control period (p=0.023). There was no significant change in therapeutic management. The use of genomic testing was significantly increased. The number of breast cancer cases diagnosed decreased by 30% during the first COVID-19 lockdown. Even though a rebound was expected after the first wave, the number of consultations for breast cancer remained constant. This finding shows the fragility of screening adherence.

CONCLUSION:

It is necessary to reinforce education in the face of crises that may be repeated. Management of breast cancer did not change, which is a reassuring aspect regarding the care pathway in anticancer centers.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Female / Humans Language: English Journal: Anticancer Res Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Female / Humans Language: English Journal: Anticancer Res Year: 2023 Document Type: Article